Most "investors" in OTC stocks are short-term scalpers. They don't have the patience to stick around, which is understandable since most OTC companies aren't run for shareholders benefit. Balance sheets are key IMO.
I'm in this one because the balance sheet is strong, the industry backdrop is great and I think the management and advisory team are well above average. I think those buying down here are getting a gift and the stock will easily take out its prior year highs at some point in the next year.
News 
Market Data 
Discover 
AI
